Sometimes events overtake my intentions. I'd been reading the scientific literature on drugs and social policy, hoping to gain a balanced and critical view of the looming possibility of decriminalisation and even legalisation of drug use for adults. Then legalisation of cannabis in Uruguay and especially in Colorado occurred and opponents of legalisation emerged.
The problem isn't that there's not enough research into cannabis. The problem is that when seeking a balance between opposing views - to seek facts, not ideology - the science supporting opposition to legalisation is so weak.
Opponents recite the statistic that one out of six adolescents will become addicted. Leaving aside the flawed concept of addiction, an opiate-based misconception with little applicability to cannabis, the quoted figure is questionable. It is based on one retrospective study of 18-year-old frequent users. A recent review found the figure for dependency-potential in adolescents was closer to one in 17.
Colorado's law restricts cannabis to those over 21.
More significant is the study quoted in The Lancet linking smoking marijuana to later onset of schizophrenia. That study of Swedish users does contend a rate of later schizophrenia 2.4 times that of non-users. However, schizophrenia is relatively rare. The incidence in Sweden is 0.0018 per cent. Putting aside issues of diagnostic accuracy and factors that may be common to drug use and mental illness, 2.4 x 0.0018 is still a very low number.